文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Digestive Enzyme Supplementation in Gastrointestinal Diseases.

作者信息

Ianiro Gianluca, Pecere Silvia, Giorgio Valentina, Gasbarrini Antonio, Cammarota Giovanni

机构信息

Department of Medical Sciences, Division of Internal Medicine, Gastroenterology and Liver Unit, Catholic University, School of Medicine and Surgery, A. Gemelli Hospital Rome, Italy, Largo A. Gemelli 8, IT-00168 Rome, Italy.

出版信息

Curr Drug Metab. 2016;17(2):187-93. doi: 10.2174/138920021702160114150137.


DOI:10.2174/138920021702160114150137
PMID:26806042
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4923703/
Abstract

BACKGROUND: Digestive enzymes are able to break down proteins and carbohydrates and lipids, and their supplementation may play a role in the management of digestive disorders, from lactose intolerance to cystic fibrosis. To date, several formulations of digestive enzymes are available on the market, being different each other in terms of enzyme type, source and origin, and dosage. METHODS: This review, performed through a non-systematic search of the available literature, will provide an overview of the current knowledge of digestive enzyme supplementation in gastrointestinal disorders, discussion of the use of pancreatic enzymes, lactase (β-galactosidase) and conjugated bile acids, and also exploring the future perspective of digestive enzyme supplementation. RESULTS: Currently, the animal-derived enzymes represent an established standard of care, however the growing study of plant-based and microbe-derived enzymes offers great promise in the advancement of digestive enzyme therapy. CONCLUSION: New frontiers of enzyme replacement are being evaluated also in the treatment of diseases not specifically related to enzyme deficiency, whereas the combination of different enzymes might constitute an intriguing therapeutic option in the future.

摘要

相似文献

[1]
Digestive Enzyme Supplementation in Gastrointestinal Diseases.

Curr Drug Metab. 2016

[2]
The role of enzyme supplementation in digestive disorders.

Altern Med Rev. 2008-12

[3]
Digestive Enzyme Replacement Therapy: Pancreatic Enzymes and Lactase.

Medsurg Nurs. 2016

[4]
[Digestive enzyme preparations].

Fortschr Med. 1974-7-4

[5]
Enzyme supplementation in digestive disorders.

West Med Med J West. 1962-12

[6]
Editorial overview: Gastrointestinal: New frontiers in therapeutics for GI diseases and disorders-from microRNAs to novel pharmaceutics, to low FODMAP diets and microbiome.

Curr Opin Pharmacol. 2017-12

[7]
Gastrointestinal neuropharmacology: identification of therapeutic targets.

Curr Opin Pharmacol. 2002-12

[8]
[Clinical efficacy test of a digestive enzyme preparation--a blind study].

Med Welt. 1972-11-18

[9]
Lactose intolerance: a non-allergic disorder often managed by allergologists.

Eur Ann Allergy Clin Immunol. 2009-2

[10]
[Role of the digestive flora in adaptation to lactose consumption in rats].

Int J Vitam Nutr Res. 1978

引用本文的文献

[1]
Lactose Intolerance and Malabsorption Revisited: Exploring the Impact and Solutions.

GE Port J Gastroenterol. 2025-4-21

[2]
Thiamine, gastrointestinal beriberi and acetylcholine signaling.

Front Nutr. 2025-4-9

[3]
Potential Roles of Exogenous Proteases and Lipases as Prebiotics.

Nutrients. 2025-3-6

[4]
Education, intelligence, and 20 gastrointestinal disorders: A Mendelian randomization study.

Medicine (Baltimore). 2024-12-6

[5]
Harnessing the Anti-Inflammatory Properties of Polyphenols in the Treatment of Inflammatory Bowel Disease.

Int J Biol Sci. 2024

[6]
Evaluation of probiotic efficacy of indigenous yeast strain, Saccharomyces cerevisiae Y-89 isolated from a traditional fermented beverage of West Bengal, India having protective effect against DSS-induced colitis in experimental mice.

Arch Microbiol. 2024-9-10

[7]
Acute physiological effects on macromolecule digestion following oral ingestion of the enzyme blend Elevase® in individuals that had undergone an ileostomy, but were otherwise healthy-a randomized, double blinded, placebo-controlled exploratory study.

Front Nutr. 2024-7-16

[8]
Diet management in congenital diarrheas and enteropathies - general concepts and disease-specific approach, a narrative review.

Am J Clin Nutr. 2024-7

[9]
simulated study of macronutrient digestion in complex food using digestive enzyme supplement.

Heliyon. 2024-4-25

[10]
Added Value of C Analysis in Breath Tests in H-Negative Subjects to Diagnose Lactose Malabsorption: A Proof of Concept Study.

Dig Dis Sci. 2024-6

本文引用的文献

[1]
Therapeutic modulation of gut microbiota: current clinical applications and future perspectives.

Curr Drug Targets. 2014

[2]
Coeliac disease: an old or a new disease? History of a pathology.

Intern Emerg Med. 2014-4

[3]
Pharmacological pain management in chronic pancreatitis.

World J Gastroenterol. 2013-11-14

[4]
Randomised clinical trial: a 1-week, double-blind, placebo-controlled study of pancreatin 25 000 Ph. Eur. minimicrospheres (Creon 25000 MMS) for pancreatic exocrine insufficiency after pancreatic surgery, with a 1-year open-label extension.

Aliment Pharmacol Ther. 2013-2-5

[5]
Celiac disease: advances in treatment via gluten modification.

Clin Gastroenterol Hepatol. 2012-6-19

[6]
The rosemont criteria can predict the pain response to pancreatic enzyme supplementation in patients with suspected chronic pancreatitis undergoing endoscopic ultrasoun.

Gut Liver. 2011-11-21

[7]
International phase III trial of liprotamase efficacy and safety in pancreatic-insufficient cystic fibrosis patients.

J Cyst Fibros. 2011-8-9

[8]
Pancreatic enzyme supplementation.

Curr Opin Pediatr. 2011-10

[9]
A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery.

Aliment Pharmacol Ther. 2011-3-21

[10]
Bile acids for primary sclerosing cholangitis.

Cochrane Database Syst Rev. 2011-1-19

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索